Indonesia
· Delayed Price · Currency is IDR IDX:LABS Statistics
Total Valuation
IDX:LABS has a market cap or net worth of IDR 485.85 billion. The enterprise value is 479.24 billion.
| Market Cap | 485.85B |
| Enterprise Value | 479.24B |
Important Dates
The last earnings date was Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:LABS has 3.95 billion shares outstanding.
| Current Share Class | 3.95B |
| Shares Outstanding | 3.95B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 9.87% |
| Owned by Institutions (%) | n/a |
| Float | 700.00M |
Valuation Ratios
The trailing PE ratio is 164.57.
| PE Ratio | 164.57 |
| Forward PE | n/a |
| PS Ratio | 3.29 |
| PB Ratio | 3.50 |
| P/TBV Ratio | 3.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.45, with an EV/FCF ratio of -23.39.
| EV / Earnings | 162.33 |
| EV / Sales | 3.25 |
| EV / EBITDA | 22.45 |
| EV / EBIT | 53.53 |
| EV / FCF | -23.39 |
Financial Position
The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.26.
| Current Ratio | 3.02 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 1.68 |
| Debt / FCF | -1.75 |
| Interest Coverage | 2.94 |
Financial Efficiency
Return on equity (ROE) is 3.14% and return on invested capital (ROIC) is 4.22%.
| Return on Equity (ROE) | 3.14% |
| Return on Assets (ROA) | 3.08% |
| Return on Invested Capital (ROIC) | 4.22% |
| Return on Capital Employed (ROCE) | 5.93% |
| Revenue Per Employee | 2.38B |
| Profits Per Employee | 47.62M |
| Employee Count | 62 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 114.20 |
| 200-Day Moving Average | 132.78 |
| Relative Strength Index (RSI) | 70.68 |
| Average Volume (20 Days) | 798,210 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:LABS had revenue of IDR 147.64 billion and earned 2.95 billion in profits. Earnings per share was 0.75.
| Revenue | 147.64B |
| Gross Profit | 56.76B |
| Operating Income | 8.95B |
| Pretax Income | 5.29B |
| Net Income | 2.95B |
| EBITDA | 21.11B |
| EBIT | 8.95B |
| Earnings Per Share (EPS) | 0.75 |
Balance Sheet
The company has 42.55 billion in cash and 35.94 billion in debt, giving a net cash position of 6.61 billion or 1.67 per share.
| Cash & Cash Equivalents | 42.55B |
| Total Debt | 35.94B |
| Net Cash | 6.61B |
| Net Cash Per Share | 1.67 |
| Equity (Book Value) | 138.75B |
| Book Value Per Share | 35.13 |
| Working Capital | 106.42B |
Cash Flow
In the last 12 months, operating cash flow was -13.68 billion and capital expenditures -6.81 billion, giving a free cash flow of -20.49 billion.
| Operating Cash Flow | -13.68B |
| Capital Expenditures | -6.81B |
| Free Cash Flow | -20.49B |
| FCF Per Share | -5.19 |
Margins
Gross margin is 38.44%, with operating and profit margins of 6.06% and 2.00%.
| Gross Margin | 38.44% |
| Operating Margin | 6.06% |
| Pretax Margin | 3.58% |
| Profit Margin | 2.00% |
| EBITDA Margin | 14.30% |
| EBIT Margin | 6.06% |
| FCF Margin | n/a |
Dividends & Yields
IDX:LABS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.61% |
| FCF Yield | -4.22% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDX:LABS has an Altman Z-Score of 6.71.
| Altman Z-Score | 6.71 |
| Piotroski F-Score | n/a |